Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg(Memorial Sloan Kettering Cancer Center), Jean Hoffman‐Censits(Sidney Kimmel Cancer Center), Tom Powles(Barts Health NHS Trust), Michiel S. van der Heijden(The Netherlands Cancer Institute), Arjun Vasant Balar(NYU Langone Health), Andrea Necchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Nancy A. Dawson(MedStar Georgetown University Hospital), Peter H. O’Donnell(University of Chicago), Ani Sarkis Balmanoukian(Angeles Clinic and Research Institute), Yohann Loriot(Institut Gustave Roussy), Sandy Srinivas(Stanford University), Margitta Retz(Technical University of Munich), Petros Grivas(Cleveland Clinic), Richard W. Joseph(Mayo Clinic in Florida), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Mark T. Fleming(Virginia Oncology Associates), Daniel P. Petrylak(Yale University), José Luis Perez‐Gracia(Clinica Universidad de Navarra), Howard A. Burris(Tennessee Oncology), Daniel Castellano(Research Institute Hospital 12 de Octubre), Christina Canil(Ottawa Hospital), Joaquim Bellmunt(Dana-Farber Cancer Institute), Dean F. Bajorin(Memorial Sloan Kettering Cancer Center), Dorothee Nickles, Richard Bourgon, Garrett M. Frampton(Foundation Medicine (United States)), Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer(University of Virginia)
Cited by 3,710
Abstract
Related Papers
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al.|International Journal of Cancer|2014|29k